Adverum Biotechnologies (ADVM) Tops Q4 EPS by 11c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 EPS of ($0.23), $0.11 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• CoStar Group acquires Zonda for $800M, adding new home data